Hubert Fernandez

Hubert Fernandez

UNVERIFIED PROFILE

Are you Hubert Fernandez?   Register this Author

Register author
Hubert Fernandez

Hubert Fernandez

Publications by authors named "Hubert Fernandez"

Are you Hubert Fernandez?   Register this Author

99Publications

2659Reads

40Profile Views

Defining the spectrum of spasticity-associated involuntary movements.

Parkinsonism Relat Disord 2019 Aug 12;65:79-85. Epub 2019 May 12.

The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2019.05.007DOI Listing
August 2019

Tardive Dyskinesia: Treatment Update.

Curr Neurol Neurosci Rep 2019 Aug 16;19(9):69. Epub 2019 Aug 16.

Center for Neurological Restoration, Cleveland Clinic, 9500 Euclid Avenue, S-3, Cleveland, OH, 44198, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-019-0976-1DOI Listing
August 2019

Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes.

Heliyon 2019 Jun 25;5(6):e01862. Epub 2019 Jun 25.

Center for Neurological Restoration, Cleveland Clinic, 9500 Euclid Avenue, Desk U2, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.heliyon.2019.e01862DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600002PMC
June 2019

Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats.

Mov Disord Clin Pract 2019 Apr 27;6(4):336-337. Epub 2019 Mar 27.

University of Alabama at Birmingham Birmingham Alabama USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476597PMC
April 2019

Exploring bedside clinical features of parkinsonism: A focus on differential diagnosis.

Parkinsonism Relat Disord 2019 Feb 5;59:74-81. Epub 2018 Nov 5.

Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13538020183048
Publisher Site
http://dx.doi.org/10.1016/j.parkreldis.2018.11.005DOI Listing
February 2019

Current treatment of tardive dyskinesia.

Parkinsonism Relat Disord 2019 Feb 19;59:155-160. Epub 2018 Dec 19.

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, S-3, Cleveland, OH, 44195, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13538020183055
Publisher Site
http://dx.doi.org/10.1016/j.parkreldis.2018.12.022DOI Listing
February 2019

The next chapter in symptomatic Parkinson disease treatments.

Parkinsonism Relat Disord 2019 Feb 3;59:39-48. Epub 2019 Jan 3.

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2019.01.002DOI Listing
February 2019

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Neurology 2019 Feb;92(7):329-337

From the UC Gardner Neuroscience Institute and Gardner Family Center for Parkinson's Disease and Movement Disorders (A.J.E., J.A.V., L.M., A.M.), Department of Neurology, University of Cincinnati, OH; Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic (A.E.L., A.F.), Toronto Western Hospital, University of Toronto; Krembil Research Institute (A.E.L., A.F.), Toronto, Canada; Parkinson's Disease and Movement Disorders Center (D.K.S.), Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; College of Medicine (K.A.J.), Mayo Clinic, Rochester, MN; Institute of Molecular and Clinical Sciences (F.M.), St George's University of London, UK; Division of Movement Disorders (R.S.), Department of Neurology and Department of Health Science Research, Mayo Clinic College of Medicine, Rochester, MN; Department of Neurology and the Pittsburgh Institute for Neurodegenerative Diseases (J.T.G., F.C.), University of Pittsburgh, PA; Department of Neurology (T.R.Y.), University of Kentucky, Lexington; Parkinson's Disease Research, Education and Clinical Center (C.M.T.), Neurology, San Francisco Veterans Affairs Medical Center; Department of Neurology (C.M.T.), University of California-San Francisco; Department of Neurology & Neurosurgery, Montreal Neurological Institute, and Department of Human Genetics (Z.G.-O.), McGill University, Canada; Parkinson & Other Movement Disorders Center UC San Diego (I.L.), Department of Neurosciences, Altman Clinical Translational Research Institute, La Jolla, CA; VA Puget Sound Health Care System and Department of Neurology (I.F.M., CP.Z.), University of Washington, Seattle; Department of Neurology (I.F.M.), University of Washington School of Medicine, Seattle; Center for Neurodegenerative Science (P.B.), Van Andel Research Institute, Grand Rapids, MI; Center for Neurological Restoration (H.H.F.) and Lou Ruvo Center for Brain Health, Neurological Institute (J.B.L.), Cleveland Clinic, OH; Department of Neurology (D.G.S.), University of Alabama at Birmingham; Consultorio y Laboratorio de Neurogenética (M.A.K.), Centro Universitario de Neurología "José María Ramos Mejía" y División Neurología, Hospital JM Ramos Mejía, Facultad de Medicina, UBA; Programa de Medicina de Precision y Genomica Clinica (M.A.K.), Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, Universidad Austral-CONICET, Buenos Aires, Argentina; Department of Neurology (M.A.S.), Massachusetts General Hospital, Boston; Division of Neuroscience (S.P.S.), Sanofi-Genzyme, Framingham, MA; Michael J. Fox Foundation for Parkinson's Research (T.S.), New York, NY; and College of Sciences (G.P.), University of Texas at San Antonio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382364PMC
February 2019

Movement disorders in early MS and related diseases: A prospective observational study.

Neurol Clin Pract 2019 Feb;9(1):24-31

Multiple Sclerosis and Neuroimmunology Program (HA), University Hospitals of Cleveland; Case Western Reserve University School of Medicine (HA, KK), Cleveland; and Center for Neurological Restoration (XXY, HHF) and The Mellen Center for Multiple Sclerosis Treatment and Research (JAC), Cleveland Clinic, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382384PMC
February 2019

Highlights of the XXIII World Congress on Parkinson's Disease and Related Disorders.

Parkinsonism Relat Disord 2019 Feb;59

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2019.03.011DOI Listing
February 2019

Predicting early cognitive decline in newly-diagnosed Parkinson's patients: A practical model.

Parkinsonism Relat Disord 2018 11 19;56:70-75. Epub 2018 Jun 19.

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Psychiatry and Psychology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.06.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425482PMC
November 2018

Rationale and patient selection for interventional therapies in Parkinson's disease.

Expert Rev Neurother 2018 Nov;18(11):811-823

i Parkinson's, Movement Disorders and Neurorestoration Program , National Neuroscience Institute , Riyadh , Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2018.1535902DOI Listing
November 2018

The Safety and Efficacy of Using the O-Arm Intraoperative Imaging System for Deep Brain Stimulation Lead Implantation.

Neuromodulation 2018 Aug 20;21(6):588-592. Epub 2017 Dec 20.

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ner.12744DOI Listing
August 2018

The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?

Parkinsonism Relat Disord 2018 06 2;51:9-16. Epub 2018 Feb 2.

Department of Neurology, Institute for Research and Medical Care, IRCCS San Raffaele Roma, Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.02.001DOI Listing
June 2018

Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson's disease.

J Neurosurg 2018 Jun 22:1-6. Epub 2018 Jun 22.

1Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, Ohio; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2018.1.JNS171660DOI Listing
June 2018

Lack of Accurate Self-appraisal is Equally Likely in MCI from Parkinson's Disease and Alzheimer's Disease.

Mov Disord Clin Pract 2018 May-Jun;5(3):283-289. Epub 2018 Mar 23.

Lou Ruvo Center for Brain Health Cleveland Clinic Cleveland OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174380PMC
March 2018

Deep Brain Stimulation in Parkinson's Disease.

Parkinsons Dis 2018 7;2018:9625291. Epub 2018 Feb 7.

Parkinson's, Movement Disorders and Neurorestoration Program, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/9625291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821949PMC
February 2018

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Neurology 2018 01 13;90(2):74-82. Epub 2017 Dec 13.

From Muhammad Ali Parkinson Center (R.R.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (F.K., G.K.W., W.P., K.S., N.S.), Medical University Innsbruck, Austria; National Institute of Neurological Disorders and Stroke (W.R.G., W.J.K.), NIH, Bethesda, MD; Department of Neurology (P.A.L.), Mayo Clinic, Rochester, MN; Brain and Mind Centre (G.H.), Sydney Medical School, the University of Sydney; UNSW Medicine & Neuroscience Research Australia (G.H.), Sydney; Queen Square Brain Bank (J.H.), UCL Institute of Neurology (N.P.Q.), London, UK; UPS, INSERM, and CHU de Toulouse (O.R.), University de Toulouse; Centre de Référence Maladie Rare contre l'AMS (O.R.), Centre d'Investigation Clinique CIC1436, Départments de Pharmacologie Clinique et de Neurosciences, NeuroToul/COEN Center of Excellence in Neurodegeneration, Toulouse, France; Department of Pathology & Laboratory Medicine (L.M.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Manhasset, NY; The Multiple System Atrophy (MSA) Coalition, Inc. (P. B., J.B., P.F., L.K., C.L., C.R., S.S.), Charlotte, NC; Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Las Vegas, NV; Medical Affairs (V.A.), Teva Pharmaceuticals, Frazer, PA; Department of Neurology (G.B.), David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles; Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK; Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, Grand Rapids, MI; Center for Neurological Restoration (H.F.), Cleveland Clinic, OH; Defeat MSA (P.F.); MSA Shoe Charity (P.F., C.R.), Saint Clair Shores, MI; Department of Neurology (R.F.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurodegenerative Diseases (T.G.), Hertie Institute of Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.), Tübingen, Germany; Lundbeck LLC (A.H.), Deerfield, IL; German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Munich; Department of Neurology (G.U.H.), Technical University of Munich, Germany; Neurogenomics Division (M.J.H.), The Translational Genomics Research Institute, Phoenix, AZ; Dandrite & Department of Biomedicine (P.H.J.), Aarhus University, Denmark; Quanterix (A.J.), Lexington, MA; Department of Neurology (U.J.K.), Columbia University Medical Center; Department of Neurology (H.K.), New York University School of Medicine, New York; Whitehead Institute for Biomedical Research (V.K.), Cambridge; Ann Romney Center for Neurologic Disease (V.K.), Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard Stem Cell Institute (V.K.), Cambridge, MA; Department of Neurology (T.K.), University of Bonn; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Bonn, Germany; Brain and Mind Centre (W.S.K.), Sydney Medical School, University of Sydney, Australia; Department of Neurology (P.L.), Henry Ford Hospital; Department of Neurology (P.L.), Wayne State University School of Medicine, Detroit, MI; Division of Neurosciences (E.M.), National Institute on Aging/NIH, Bethesda, MD; Centre de Référence Maladie Rare AMS (W.M.), Hôpital Pellegrin, CHU de Bordeaux; Université de Bordeaux (W.M.), Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux; Paris Saclay Institute of Neuroscience (R.M.), CNRS, Gif-sur-Yvette, France; Genentech Inc. (S.O.), South San Francisco; Cedars-Sinai Medical Center (S.P.), Los Angeles, CA; Department of Neurology (D.R.), Vanderbilt University Medical Center, Nashville, TN; MSA NJ (C.R.), Howell, NJ; Prothena Biosciences (D.S.), South San Francisco, CA; Division of Neurology (M.S.), Department of Medicine, The Ottawa Hospital, Canada; Department of Neurology (J.D.S.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Cure MSA Foundation (L.S.), Fremont, CA; Avid Radiopharmaceuticals (A.S.), Philadelphia, PA; Department of Neurological Sciences (G.T.S.), Rush University Medical Center, Chicago, IL; Department of Neurology (S.T.), Graduate School of Medicine, Tokyo University, Tokyo, Japan; and University of Washington (J.Z.), Seattle. W.R.G. is currently affiliated with Janssen Research and Development, Titusville, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772155PMC
January 2018

The beginning of our new journey.

Parkinsonism Relat Disord 2018 01;46

Cleveland Clinic Neurological Institute, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.12.028DOI Listing
January 2018

Cognitive Impact of Deep Brain Stimulation on Parkinson's Disease Patients.

Parkinsons Dis 2017 22;2017:3085140. Epub 2017 Nov 22.

University of Florida, Gainesville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/3085140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735627PMC
November 2017

DBS Programming: An Evolving Approach for Patients with Parkinson's Disease.

Parkinsons Dis 2017 24;2017:8492619. Epub 2017 Sep 24.

University of Texas Health Science Center, McGovern Medical School, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/8492619DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632902PMC
September 2017

Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson disease treatment center.

J Neurol Sci 2017 Aug 16;379:308-311. Epub 2017 Jun 16.

Center of Neurologic Restoration, Cleveland Clinic, 9500 Euclid Ave/U2, Cleveland, OH 44195, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2017.06.022DOI Listing
August 2017

Goggle-like Appearance of Injured Cerebellothalamic Axons Surrounding Red Nuclei in Holmes Tremor.

Can J Neurol Sci 2017 Jul 15;44(4):429-431. Epub 2016 Dec 15.

4Department of Neurology,University of Minnesota,Minneapolis,Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2016.418DOI Listing
July 2017

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.

Neurology 2017 May 26;88(21):2003-2010. Epub 2017 Apr 26.

From the Cleveland Clinic (H.H.F.), Center for Neurological Restoration, Cleveland, OH; Emory University (S.A.F.), Atlanta, GA; University of South Florida Parkinson's Disease and Movement Disorders Center (R.A.H.), Tampa, FL; Baylor College of Medicine (J.J.-S.), Houston, TX; Methodist Neurological Institute (W.G.O.), Houston, TX; University of North Carolina School of Medicine (L.F.J.), Chapel Hill, NC; Northwestern University Feinberg School of Medicine (H.Y.M., D.B.), Chicago, IL; Yale School of Medicine (S.W.W.), New Haven, CT; University of Tennessee Health Science Center (M.S.L.), Memphis, TN; University of Utah Health Care (D.R.S.), Salt Lake City, UT; Banner Sun Health Research Institute (D.R.S.), Sun City, AZ; CSD Biostatistics (C.D.), Tucson, AZ; Teva Pharmaceutical Industries (M.D.D.), Frazer, PA; Teva Pharmaceuticals (D.S.), La Jolla, CA; and Georgetown University (K.E.A.), Washington, DC.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000003960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440239PMC
May 2017

Dopamine agonist withdrawal syndrome: A comprehensive review.

J Neurol Sci 2017 Mar 2;374:53-55. Epub 2017 Jan 2.

Center for Neurological Restoration, Cleveland Clinic, 9500 Euclid Ave U2, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2016.12.070DOI Listing
March 2017

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Mov Disord 2017 03 24;32(3):319-324. Epub 2017 Feb 24.

Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital and The Edmond J. Safra Program in PD, Toronto, Ontario, Canada, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359057PMC
March 2017

Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.

Neurology 2016 11 5;87(18):1907-1915. Epub 2016 Oct 5.

From the New York University School of Medicine (M.B., S.A., M.B., G.D., P.K., A.D.R.), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, New York; Berenson-Allen Center for Noninvasive Brain Stimulation (M.D.F., Z.G., A.P.-L.), Division of Cognitive Neurology, and Parkinson's Disease and Movement Disorders Center (D.K.S., A.P.-L.), Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Department of Neurology (A.W.) and Ahmanson-Lovelace Brain Mapping Center (A.W.), University of California School of Medicine, Los Angeles; Cleveland Clinic (H.F.), Department of Neurology, OH; Toronto Western Research Institute (R.C.), University of Toronto, Ontario, Canada; University of Florida (A.W.S.), Department of Neurology, Gainesville; University of North Dakota School of Medicine (J.-S.L.), Department of Neurology, Grand Forks; and Center for Brain Health (E.P.), NYU School of Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100715PMC
November 2016

Current Understanding of Psychosis in Parkinson's Disease.

Curr Psychiatry Rep 2016 10;18(10):97

Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11920-016-0730-1DOI Listing
October 2016

Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.

Am J Alzheimers Dis Other Demen 2016 08 16;31(5):430-6. Epub 2016 Feb 16.

Department of Neurology, Cleveland Clinic, Cleveland, OH, USA Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1533317515628053DOI Listing
August 2016

Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease.

NPJ Parkinsons Dis 2016 14;2:16015. Epub 2016 Jul 14.

Klinikum Bermerhaven, Bremerhaven, Germany and Skane University Hospital, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npjparkd.2016.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516571PMC
July 2016

Spinal Movement Disorders in Neuromyelitis Optica: An Under-recognized Phenomenon.

Mov Disord Clin Pract 2016 Nov-Dec;3(6):596-602. Epub 2016 Feb 11.

Johns Hopkins University Baltimore Maryland USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353421PMC
February 2016

Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort.

J Clin Mov Disord 2014 26;1. Epub 2014 Nov 26.

Departments of Neurology, Neurosurgery and Psychiatry, McKnight Brain Institute, University of Florida, 100 S Newell Dr Rm-L3-101, Gainesville, 32611 FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2054-7072-1-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711001PMC
January 2016

Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease.

Neuromodulation 2016 Jan 15;19(1):25-30. Epub 2015 Jun 15.

Cleveland Clinic, Neurological Institute, Center for Neurological Restoration, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ner.12324DOI Listing
January 2016

Is it time for flexibility in botulinum inter-injection intervals?

Toxicon 2015 Dec 9;107(Pt A):72-6. Epub 2015 Oct 9.

Center for Neurologic Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxicon.2015.09.037DOI Listing
December 2015

Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center.

Mov Disord Clin Pract 2016 Jan-Feb;3(1):31-35. Epub 2015 Oct 28.

Center of Neurological Restoration Department of Neurology Cleveland Clinic Cleveland Ohio USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178596PMC
October 2015

2015 Update on Parkinson disease.

Cleve Clin J Med 2015 Sep;82(9):563-8

Section Head, Center for Neuro-Restoration, Cleveland Clinic, Cleveland, OH, USA. E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.82gr.15004DOI Listing
September 2015

Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease.

Parkinsonism Relat Disord 2015 Mar 31;21(3):249-53. Epub 2014 Dec 31.

Center for Neurological Restoration, Cleveland Clinic, 9500 Euclid Avenue, Mail Code U2, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2014.12.018DOI Listing
March 2015

Unusual case of levodopa-responsive camptocormia in a patient with negative dopamine transporter scan and normal DYT 5 gene.

Clin Neuropharmacol 2014 Mar-Apr;37(2):63-4

*Center for Neurological Restoration, Cleveland Clinic Foundation; and †Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0000000000000024DOI Listing
February 2015

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Authors:
M Flint Beal David Oakes Ira Shoulson Claire Henchcliffe Wendy R Galpern Richard Haas Jorge L Juncos John G Nutt Tiffini Smith Voss Bernard Ravina Clifford M Shults Karen Helles Victoria Snively Mark F Lew Brian Griebner Arthur Watts Shan Gao Emmanuelle Pourcher Louisette Bond Katie Kompoliti Pinky Agarwal Cherissa Sia Mandar Jog Linda Cole Munira Sultana Roger Kurlan Irene Richard Cheryl Deeley Cheryl H Waters Angel Figueroa Ani Arkun Matthew Brodsky William G Ondo Christine B Hunter Joohi Jimenez-Shahed Alicia Palao Janis M Miyasaki Julie So James Tetrud Liza Reys Katharine Smith Carlos Singer Anita Blenke David S Russell Candace Cotto Joseph H Friedman Margaret Lannon Lin Zhang Edward Drasby Rajeev Kumar Thyagarajan Subramanian Donna Stuppy Ford David A Grimes Diane Cote Jennifer Conway Andrew D Siderowf Marian Leslie Evatt Barbara Sommerfeld Abraham N Lieberman Michael S Okun Ramon L Rodriguez Stacy Merritt Camille Louise Swartz W R Wayne Martin Pamela King Natividad Stover Stephanie Guthrie Ray L Watts Anwar Ahmed Hubert H Fernandez Adrienna Winters Zoltan Mari Ted M Dawson Becky Dunlop Andrew S Feigin Barbara Shannon Melissa Jill Nirenberg Mattson Ogg Samuel A Ellias Cathi-Ann Thomas Karen Frei Ivan Bodis-Wollner Sofya Glazman Thomas Mayer Robert A Hauser Rajesh Pahwa April Langhammer Ranjit Ranawaya Lorelei Derwent Kapil D Sethi Buff Farrow Rajan Prakash Irene Litvan Annette Robinson Alok Sahay Maureen Gartner Vanessa K Hinson Samuel Markind Melisa Pelikan Joel S Perlmutter Johanna Hartlein Eric Molho Sharon Evans Charles H Adler Amy Duffy Marlene Lind Lawrence Elmer Kathy Davis Julia Spears Stephanie Wilson Maureen A Leehey Neal Hermanowicz Shari Niswonger Holly A Shill Sanja Obradov Alex Rajput Marilyn Cowper Stephanie Lessig David Song Deborah Fontaine Cindy Zadikoff Karen Williams Karen A Blindauer Jo Bergholte Clara Schindler Propsom Mark A Stacy Joanne Field Dragos Mihaila Mark Chilton Ergun Y Uc Jeri Sieren David K Simon Lauren Kraics Althea Silver James T Boyd Robert W Hamill Christopher Ingvoldstad Jennifer Young Karen Thomas Sandra K Kostyk Joanne Wojcieszek Ronald F Pfeiffer Michel Panisset Monica Beland Stephen G Reich Michelle Cines Nancy Zappala Jean Rivest Richard Zweig L Pepper Lumina Colette Lynn Hilliard Stephen Grill Marye Kellermann Paul Tuite Susan Rolandelli Un Jung Kang Joan Young Jayaraman Rao Maureen M Cook Lawrence Severt Karyn Boyar

JAMA Neurol 2014 May;71(5):543-52

Department of Neurology, Beth Israel Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.131DOI Listing
May 2014

Correlations of apathy and depression with postural instability in Parkinson disease.

J Neurol Sci 2014 Mar 2;338(1-2):162-5. Epub 2014 Jan 2.

Department of Neurology, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2013.12.040DOI Listing
March 2014

Diffusion, spread, and migration of botulinum toxin.

Mov Disord 2013 Nov 18;28(13):1775-83. Epub 2013 Jul 18.

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25582DOI Listing
November 2013

A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.

Tremor Other Hyperkinet Mov (N Y) 2013 10;3. Epub 2013 Oct 10.

Departments of Neurology, and Neurosurgery, University of Florida, Center for Movement Disorders & Neurorestoration, Gainesville, FL, USA ; Military Central Hospital, Bogota, Colombia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822405PMC
http://dx.doi.org/10.7916/D86W98SWDOI Listing
November 2013

Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.

J Neural Transm (Vienna) 2013 Sep 23;120(9):1345-53. Epub 2013 Feb 23.

Parkinson's and Movement Disorder Institute, 9940 Talbert Avenue, Fountain Valley, California, 92708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-013-0998-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751217PMC
September 2013

Rankin scale as a potential measure of global disability in early Parkinson's disease.

J Clin Neurosci 2013 Sep 26;20(9):1200-3. Epub 2013 Jun 26.

Northwestern University Feinberg School of Medicine, Abbott Hall 11th Floor, 710 North Lake Shore Drive, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2012.10.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947899PMC
September 2013

Sustained benefit of painful legs moving toes syndrome with botulinum toxin type A.

J Clin Neurosci 2013 Jul 9;20(7):1031-2. Epub 2013 Apr 9.

Center for Movement Disorders and Neurorestoration, University of Florida College of Medicine, Gainesville, FL 32607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2012.06.016DOI Listing
July 2013

Successful deep brain stimulation surgery with intraoperative magnetic resonance imaging on a difficult neuroacanthocytosis case: case report.

Neurosurgery 2013 Jul;73(1):E184-7; discussion E188

Center of Neurological Restoration, Neurological Institute, Cleveland Clinic, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/01.neu.0000429852.45073.73DOI Listing
July 2013

Association of deep brain stimulation washout effects with Parkinson disease duration.

JAMA Neurol 2013 Jan;70(1):95-9

Center for Neurological Restoration, Department of Neurology, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaneurol.2013.581DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148628PMC
January 2013

Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system.

Neuromodulation 2012 May-Jun;15(3):246-50; discussion 250. Epub 2012 Feb 29.

Department of Neurology, University of Florida, Center for Movement Disorders and Neurorestoration, McKnight Brain Institute, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1525-1403.2012.00437.xDOI Listing
November 2012

Nonmotor complications of Parkinson disease.

Cleve Clin J Med 2012 Jul;79 Suppl 2:S14-8

Movement Disorders Program, Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
https://www.mdedge.com/ccjm/article/95787/neurology/nonmotor
Publisher Site
http://dx.doi.org/10.3949/ccjm.79.s2a.03DOI Listing
July 2012

Istradefylline for Parkinson's disease patients experiencing motor fluctuations: results of the KW-6002-US-018 study.

Parkinsonism Relat Disord 2012 Feb 13;18(2):178-84. Epub 2011 Oct 13.

Clinique Sainte-Anne-Laval University, 1248, Chemin Sainte-Foy, Suite # 304, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2011.09.023DOI Listing
February 2012

Deep brain stimulation: what can patients expect from it?

Cleve Clin J Med 2012 Feb;79(2):113-20

Center for Neurological Restoration, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.78gr.11006DOI Listing
February 2012

Nonmotor manifestations in Parkinson disease.

Neurologist 2012 Jan;18(1):1-16

Neurologo Clinico, Universidad Militar Nueva Granada, Bogota, Colombia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NRL.0b013e31823d7abbDOI Listing
January 2012

Updates in the medical management of Parkinson disease.

Cleve Clin J Med 2012 Jan;79(1):28-35

Center for Neurological Restoration, S31, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.78gr.11005DOI Listing
January 2012

Essential tremor: choosing the right management plan for your patient.

Cleve Clin J Med 2011 Dec;78(12):821-8

Section of Movement Disorders, Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.78a.10178DOI Listing
December 2011

The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment.

Parkinsons Dis 2011 26;2011:290195. Epub 2011 Jul 26.

University of Florida Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL 32607, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4061/2011/290195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144664PMC
November 2011

What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications.

Parkinsonism Relat Disord 2011 Nov;17 Suppl 1:S3-10

Department of Neurology and Psychiatry, University of Santo Tomas, Manila 1008, Philippines.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2011.06.019DOI Listing
November 2011

Steady or not following thalamic deep brain stimulation for essential tremor.

J Neurol 2011 Sep 27;258(9):1643-8. Epub 2011 Mar 27.

Department of Neurology, McKnight Brain Institute, University of Florida, 100 S. Newell Drive, Rm L3-100, Gainesville, Fl, 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-011-5986-0DOI Listing
September 2011

Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease.

Neurologist 2011 Sep;17(5):282-5

Department of Neurology, University of Florida Movement Disorders Center, Gainesville, FL 32610, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NRL.0b013e318217367bDOI Listing
September 2011

Two McLeod patients with novel mutations in XK.

J Neurol Sci 2011 Jun 3;305(1-2):160-4. Epub 2011 Apr 3.

New York Blood Center, Lindsley F. Kimball Research Institute, Cell Signaling Laboratory, 310E 67th street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2011.02.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337778PMC
June 2011

Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.

Neurosurgery 2011 May;68(5):1233-7; discussion 1237-8

Department of Neurology, University of Florida Movement Disorders Center McKnight Brain Institute, Gainesville, Florida 32611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e31820b52c5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090700PMC
May 2011

Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.

Parkinsonism Relat Disord 2011 May 5;17(4):285-7. Epub 2011 Feb 5.

Parkinson's Disease Treatment Center of SW Florida (d/b/a Charlotte Neurological Services), 4235 Kings Highway, Port Charlotte, FL 33980, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2011.01.007DOI Listing
May 2011

Dopamine agonists and risk: impulse control disorders in Parkinson's disease.

Brain 2011 May;134(Pt 5):1438-46

Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, Downing Site, University of Cambridge, Cambridge CB2 3EB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awr080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097893PMC
May 2011